Saturday, October 31, 2026

Cocoa Industry in Crisis: Fertilizer Shortages and Weak Demand Push Prices to New Lows

Cocoa prices hit new lows as farmers face weakening global demand and Russia-Ukraine conflict limits fertilizer exports. European Cocoa Association reports declining Q4 figures.

LM Salvado
LM Salvado

January 20, 2023

Cocoa Fruit

Cocoa farmers continue to face difficulties as global demand weakens and the conflict between Russia and Ukraine limits exports of fertilizers. Cocoa prices have dropped moderately in recent weeks, with both NY and London cocoa posting 2-week and 1-month lows, respectively.

According to the European Cocoa Association, Q4 cocoa grindings in Europe fell by 1.7% year-over-year, and the Cocoa Association of Asia reported a similar decline of 0.2% for Q4 in Asia. These weak demand figures have further weighed down already-deflated cocoa prices.

Adding to the pressure on prices, Ivory Coast farmers have sent a cumulative 1.45 million metric tons of cocoa to ports for the 2022/23 marketing year, indicating ample supplies. However, prices received a brief boost last Monday as NY cocoa rallied to an 11-month high, driven by concerns that the seasonal Harmattan winds could lead to excessive dryness.

Despite these challenges, the quarterly report from the International Cocoa Organization (ICCO) on December 1 offered some optimism for the industry. ICCO reported that global cocoa production fell by 6.8% year-over-year, potentially signaling a recovery in prices in the coming months. Nevertheless, the ongoing difficulties with fertilizer and global demand will continue to affect the industry and farmers in the meantime.

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com